Literature DB >> 30741412

Current approaches in identification and isolation of cancer stem cells.

Maryam Akbarzadeh1,2, Nazila Fathi Maroufi2,3, Abbas Pirpour Tazehkand2, Moloud Akbarzadeh1,4, Sepideh Bastani1, Reza Safdari5, Ali Farzane5, Amir Fattahi2,6, Hamid Reza Nejabati2,7, Mohammad Nouri1,2, Nasser Samadi2.   

Abstract

Cancer stem cells (CSCs) are tumor cells with initiating ability, self-renewal potential, and intrinsic resistance to conventional therapeutics. Efficient isolation and characterization of CSCs pave the way for more comprehensive knowledge about tumorigenesis, heterogeneity, and chemoresistance. Also a better understanding of CSCs will lead to novel era of both basic and clinical cancer research, reclassification of human tumors, and development of innovative therapeutic strategies. Finding novel diagnostic and effective therapeutic strategies also enhance the success of treatment in cancer patients. There are various methods based on the characteristics of the CSCs to detect and isolate these cells, some of which have recently developed. This review summarized current techniques for effective isolation and characterization of CSCs with a focus on advantages and limitations of each method with clinical applications.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  aldehyde dehydrogenase; cancer stem cell; side population; spheroid formation assay; surface marker

Year:  2019        PMID: 30741412     DOI: 10.1002/jcp.28271

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  16 in total

Review 1.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

Review 2.  Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targets.

Authors:  Takahiko Murayama; Noriko Gotoh
Journal:  Cancer Drug Resist       Date:  2019-09-19

Review 3.  Cancer stem cells in esophageal squamous cell cancer.

Authors:  Qian Wu; Zhe Wu; Cuiyu Bao; Wenjing Li; Hui He; Yanling Sun; Zimin Chen; Hao Zhang; Zhifeng Ning
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

4.  CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field.

Authors:  Zhennan Gao; Xuxia Wang; Zhan Su; Duanqin Liu; Liying Chen; Jun Zhang; Lu Ru; Zhiyu Chen
Journal:  Int J Nanomedicine       Date:  2019-09-16

5.  Discovering and Characterizing of Survivin Dominant Negative Mutants With Stronger Pro-apoptotic Activity on Cancer Cells and CSCs.

Authors:  Wei Guo; Xingyuan Ma; Yunhui Fu; Chang Liu; Qiuli Liu; Fabiao Hu; Hui Miao; Tong Zhang; Yuping Liu; Myong Hun Han; Fang You; Yi Yang; Wenyun Zheng
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

Review 6.  Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy.

Authors:  Maryam Ghanbari-Movahed; Zahra Ghanbari-Movahed; Saeideh Momtaz; Kaitlyn L Kilpatrick; Mohammad Hosein Farzaei; Anupam Bishayee
Journal:  Molecules       Date:  2021-02-12       Impact factor: 4.411

Review 7.  The Molecular Basis of Different Approaches for the Study of Cancer Stem Cells and the Advantages and Disadvantages of a Three-Dimensional Culture.

Authors:  Danila Cianciosi; Johura Ansary; Tamara Y Forbes-Hernandez; Lucia Regolo; Denise Quinzi; Santos Gracia Villar; Eduardo Garcia Villena; Kilian Tutusaus Pifarre; José M Alvarez-Suarez; Maurizio Battino; Francesca Giampieri
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

8.  ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas.

Authors:  Vei Mah; Yahya Elshimali; Alison Chu; Neda A Moatamed; Jamar P Uzzell; Jessica Tsui; Stephen Schettler; Hania Shakeri; Madhuri Wadehra
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.996

9.  FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like State.

Authors:  Athanasios Blanas; Anouk Zaal; Irene van der Haar Àvila; Maxime Kempers; Laura Kruijssen; Mike de Kok; Marko A Popovic; Joost C van der Horst; Sandra J van Vliet
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

10.  Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma.

Authors:  Nan Zhao; Fei Wang; Shaheen Ahmed; Kan Liu; Chi Zhang; Sahara J Cathcart; Dominick J DiMaio; Michael Punsoni; Bingjie Guan; Ping Zhou; Shuo Wang; Surinder K Batra; Tatiana Bronich; Tom K Hei; Chi Lin; Chi Zhang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.